Kanti R Rai Selected Research

Prolymphocytic Leukemia

2/2013	The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
1/2003	Biology and treatment of chronic lymphocytic leukemia.
9/2002	Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kanti R Rai Research Topics

Disease

55	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 05/2002
10	Neoplasms (Cancer) 01/2021 - 09/2002
7	Leukemia 04/2011 - 09/2002
6	Disease Progression 01/2021 - 12/2002
5	Infections 01/2014 - 05/2002
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2016 - 09/2002
3	Prolymphocytic Leukemia 02/2013 - 09/2002
3	Lymphoma (Lymphomas) 01/2011 - 01/2002
2	Neutropenia 01/2021 - 12/2016
2	Pneumonia (Pneumonitis) 01/2021 - 12/2016
2	Thrombocytopenia (Thrombopenia) 01/2021 - 03/2007
2	Diarrhea 01/2021 - 12/2016
2	Exanthema (Rash) 12/2016 - 10/2015
2	Hairy Cell Leukemia 10/2015 - 03/2003
2	Chromosome Aberrations (Chromosome Abnormalities) 04/2011 - 01/2011
1	Leukocytosis (Pleocytosis) 01/2021
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2017
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2017
1	Colitis 12/2016
1	Arthritis (Polyarthritis) 10/2015
1	Arthralgia (Joint Pain) 10/2015
1	Human Influenza (Influenza) 01/2014
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 10/2010
1	Virus Diseases (Viral Diseases) 10/2010
1	Listeria Meningitis 10/2010
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2010
1	Colorectal Neoplasms (Colorectal Cancer) 02/2010
1	Inflammation (Inflammations) 10/2009
1	Tumor Lysis Syndrome 03/2007
1	Opportunistic Infections (Opportunistic Infection) 03/2007
1	Second Primary Neoplasms (Neoplasms, Second) 03/2007
1	Back Pain (Backache) 10/2005
1	Fever (Fevers) 10/2005

Drug/Important Bio-Agent (IBA)

11	fludarabineIBA 02/2013 - 05/2002
10	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 12/2002
8	AntigensIBA 03/2017 - 01/2002
7	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 07/2014 - 08/2004
7	Proteins (Proteins, Gene)FDA Link 01/2014 - 12/2002
7	Alemtuzumab (Campath)FDA Link 06/2011 - 05/2002
6	AntibodiesIBA 03/2017 - 02/2004
5	Rituximab (Mabthera)FDA Link 12/2016 - 01/2003
4	purineIBA 10/2015 - 09/2002
4	Monoclonal AntibodiesIBA 05/2010 - 02/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2009 - 01/2003
3	oblimersen (G3139)IBA 11/2009 - 10/2005
3	Alkylating AgentsIBA 04/2006 - 05/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2017
2	veltuzumabIBA 01/2016 - 04/2011
2	Interleukin-17 (Interleukin 17)IBA 12/2015 - 04/2012
2	Immunoglobulin Variable RegionIBA 08/2013 - 09/2002
2	CytokinesIBA 11/2011 - 03/2007
2	Chlorambucil (Leukeran)FDA Link 06/2011 - 09/2002
2	Protein Kinases (Protein Kinase)IBA 01/2011 - 01/2011
2	MicroRNAs (MicroRNA)IBA 01/2011 - 02/2010
2	Indicators and Reagents (Reagents)IBA 01/2011 - 11/2003
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 05/2010 - 12/2008
2	EpitopesIBA 10/2009 - 11/2008
2	Antigen Receptors (Antigen Receptor)IBA 08/2004 - 04/2004
1	Phosphotransferases (Kinase)IBA 01/2021
1	EnzymesIBA 01/2021
1	umbralisibIBA 01/2021
1	thiamine triphosphorate (TTP)IBA 01/2019
1	IGF-I-IGFBP-3 complex FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	CarbohydratesIBA 03/2017
1	idelalisibIBA 12/2016
1	Transaminases (Aminotransferases)IBA 12/2016
1	Bendamustine Hydrochloride FDA Link 12/2016
1	Pharmaceutical PreparationsIBA 10/2015
1	VemurafenibIBA 10/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2015
1	AutoantigensIBA 04/2015
1	LigandsIBA 04/2015
1	NucleotidesIBA 07/2014
1	Lenalidomide (CC 5013)FDA Link 07/2014
1	Neutralizing AntibodiesIBA 01/2014
1	Hemagglutinins (Hemagglutinin)IBA 01/2014
1	Leucine (L-Leucine)FDA Link 01/2014
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2014
1	Peptides (Polypeptides)IBA 08/2013
1	anti-IgMIBA 04/2013
1	AICDA (activation-induced cytidine deaminase)IBA 12/2012
1	Biological ProductsIBA 12/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2012
1	InterleukinsIBA 04/2012
1	SuspensionsIBA 04/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2011
1	ChromatinIBA 01/2011
1	DeuteriumIBA 01/2011
1	OligodeoxyribonucleotidesIBA 12/2010
1	OligonucleotidesIBA 02/2009
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 12/2008

Therapy/Procedure

11	Therapeutics 01/2021 - 05/2002
4	Aftercare (After-Treatment) 01/2019 - 05/2002
4	Drug Therapy (Chemotherapy) 06/2011 - 02/2004
2	Subcutaneous Injections 01/2016 - 04/2011
1	Heterologous Transplantation (Xenotransplantation) 04/2016
1	Injections 01/2016
1	Drug Tapering 10/2015
1	Transplantation 05/2011